Skip to main content
. 2021 Feb 3;11:573156. doi: 10.3389/fimmu.2020.573156

Figure 4.

Figure 4

(A) Average with standard deviation of the number of CD57+ γδ lymphocytes before the beginning and after 8 days of treatment at cycles: 1, 3, and 6. (B) Time to progression of patients with a high and low (dotted line) number of CD57+ γδ lymphocytes (according to their median number) in bone marrow before the beginning of the maintenance treatment. Stars indicate statistically significant differences.